Peer review reports
From: Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
Original Submission |
6 Jun 2022 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
22 Jul 2022 |
Reviewed |
Reviewer Report
|
24 Jul 2022 |
Reviewed |
Reviewer Report
|
8 Aug 2022 |
Author responded |
Author comments - Huihua Xiong
|
Resubmission - Version 4 |
8 Aug 2022 |
Submitted |
Manuscript version 4
|
18 Aug 2022 |
Author responded |
Author comments - Huihua Xiong
|
Resubmission - Version 5 |
18 Aug 2022 |
Submitted |
Manuscript version 5
|
19 Aug 2022 |
Author responded |
Author comments - Huihua Xiong
|
Resubmission - Version 6 |
19 Aug 2022 |
Submitted |
Manuscript version 6
|
24 Aug 2022 |
Reviewed |
Reviewer Report
|
Resubmission - Version 7 |
|
Submitted |
Manuscript version 7
|
Publishing |
14 Oct 2022 |
Editorially accepted |
|
7 Nov 2022 |
Article published |
10.1186/s12876-022-02540-2
|
Learn about peer review